Oyeka C A, Gugnani H C
Department of Microbiology University of Nigeria, Nsukka.
Mycopathologia. 1990 Jun;110(3):157-61. doi: 10.1007/BF00437540.
The in vitro activity of seven azole compounds viz clotrimozole, isoconazole, bifanazole, fluconazole oxyconazole, Bay n 7133 and Bay L 9139 was investigated against 47 clinical isolates of pathogenic non-dermatophytic filamentous fungi and dermatophytic fungi. The isolates included Hendersonula toruloidea-26, Scytalidium hyalinium-5, Scytalidium japonicum-1, Trichophyton rubrum-5, Trichophyton tonsurans-3, Trichophyton mentagrophytes var. mentagrophytes-4, Epidemophyton floccosum-2, Microporum gypseum-2 isolates. The drugs were significantly more active against the dermatophytes (MIC range 0.025-1.56 micrograms/ml) than non-dermatophytes (MIC range 0.39-6.25 micrograms/ml). Isoconazole showed more activity than the rest of the azole compound tested. Clotrimazole, fluconazole, oxyconazole, bifonazole were comparable in their inhibitory activity against both dermatophytes and non-dermatophytes. The azole derivatives, Bay n 7133 and Bay L 9139 showed higher MIC range i.e. gave a range of 0.39-1.56 micrograms/ml for dermatophytes and 1.56-6.25 micrograms/ml for non-dermatophytic filamentous fungi. The minimal fungicidal concentration (MFC) of all the drugs tested were mostly within 2-8 times their MIC values.
研究了七种唑类化合物,即克霉唑、异康唑、联苯苄唑、氟康唑、奥昔康唑、Bay n 7133和Bay L 9139对47株致病性非皮肤癣菌丝状真菌和皮肤癣菌临床分离株的体外活性。这些分离株包括26株亨德逊霉、5株透明赛多孢、1株日本赛多孢、5株红色毛癣菌、3株断发毛癣菌、4株须癣毛癣菌癣菌变种、2株絮状表皮癣菌、2株石膏样小孢子菌分离株。这些药物对皮肤癣菌(MIC范围为0.025 - 1.56微克/毫升)的活性明显高于非皮肤癣菌(MIC范围为0.39 - 6.25微克/毫升)。异康唑的活性高于所测试的其他唑类化合物。克霉唑、氟康唑、奥昔康唑、联苯苄唑对皮肤癣菌和非皮肤癣菌的抑制活性相当。唑类衍生物Bay n 7133和Bay L 9139的MIC范围较高,即对皮肤癣菌的范围为0.39 - 1.56微克/毫升,对非皮肤癣菌丝状真菌的范围为1.56 - 6.25微克/毫升。所有测试药物的最小杀菌浓度(MFC)大多在其MIC值的2 - 8倍范围内。